EichorEICHOR
Study identifier: NCT07622472 Synced from ClinicalTrials.gov · August 03, 2026
● Not Yet Recruiting

Remote Monitoring and Optimization of Heart Failure Therapy

Condition: Heart Failure  ·  Sponsor: Zoll Medical Corporation

PhaseNA
Planned participants800
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Heart failure is a condition in which the heart cannot pump blood effectively, often leading to symptoms such as shortness of breath and fluid retention. After hospitalization for heart failure, patients remain at high risk of worsening symptoms, emergency visits, and hospital readmission. This study is designed to evaluate whether using a wearable monitoring device, called the Heart Failure Management System (HFMS), can help improve the management of patients after a recent hospitalization for heart failure. Participants in this study will be randomly assigned to one of two groups. One group will receive standard medical care alone. The other group will receive standard medical care in combination with the HFMS device. The HFMS device is worn on the body and continuously collects information such as heart rate, breathing, activity level, and signs of fluid accumulation. These data are reviewed by the clinical care team and may help detect early worsening of heart failure. Participants will wear the device for 90 days (if assigned to the device group) and will be followed for up to one year. During the study, information will be collected on serious health events such as death, hospitalizations, emergency visits, and changes in heart failure status, as well as quality of life. The goal of this study is to determine whether this monitoring approach can improve outcomes for patients with heart failure by enabling earlier and more effective clinical management.

This description comes directly from the study's public registry record.

Talk to the study team

Manon Lemaire, Master  ·  +33 (0)6 33 57 18 52  ·  mlemaire@zoll.com

Lars Weber, PhD  ·  +49 (0) 151 611 404 98  ·  lweber@zoll.com

Always discuss trial participation with your own doctor first.

Locations (9)

CHU NancyNancy, Grand Est, France
Justus-Liebig University GiessenGiessen, Germany
Policlinico CasilinoRoma, Italy
UMC UtrechtUtrecht, Netherlands
PIM MSWiA HospitalWarsaw, Poland
Hospital Universitario 12 de OctubreMadrid, Spain
Uppsala University HospitalUppsala, Sweden
University ZurichZurich, Switzerland
Southampton University Hospital NHS Foundation TrustSouthampton, United Kingdom

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →